Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Fixed Capital/Sales

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 1.070.800.800.890.94

What is the latest Fixed Capital/Sales ratio of CONCORD BIOTECH ?

The latest Fixed Capital/Sales ratio of CONCORD BIOTECH is 1.07 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20261.07
Mar20250.80
Mar20240.80
Mar20230.89
Mar20220.94

How is Fixed Capital/Sales of CONCORD BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2026 1.07
33.75
Mar2025 0.8
0.00
Mar2024 0.8
-10.11
Mar2023 0.89
-5.32
Mar2022 0.94 -

Other Financial Ratios of CONCORD BIOTECH


Compare Fixed Capital/Sales ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹14,856.3 Cr 13% 10.6% -30.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,312.0 Cr 3.1% 7.2% 18.3% Stock Analytics
DIVIS LABORATORIES ₹213,879.0 Cr 8.6% 20.7% 18.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹194,094.0 Cr -1.8% 4.9% 37.2% Stock Analytics
CIPLA ₹118,992.0 Cr 4.5% 1.2% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,787.4 Cr -0.7% -14.6% -8.4% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

13%

10.6%

-30.9%

SENSEX

2.7%

1.5%

-5.6%


You may also like the below Video Courses